Hungary | A breakthrough medical model developed by researchers at Semmelweis University establishes that comorbid lifestyle and neuropsychiatric variables do not simply coexist with rheumatoid arthritis—they actively sustain it. Published in Nature Reviews Rheumatology and The Lancet Rheumatology, the research targets the 6% to 28% of patients who fail to achieve lasting remission despite standard biological anti-inflammatory therapies.The team proved that non-responsive patients are often trapped in a physiological feedback loop driven by depression, sleep disorders, smoking, and obesity. These factors amplify central pain sensitivity and lower mobility, mimicking an active flare-up even when underlying tissue inflammation is clinically controlled.To prevent unnecessary over-medication, the newly proposed framework uses standard inflammatory monitoring as an early warning diagnostic system. If a patient’s laboratory markers improve but debilitating pain and fatigue persist, the model directs clinicians to pause immunosuppressive escalation and treat the root lifestyle or neuropsychiatric drivers instead. The heavily cited model is now being integrated with artificial intelligence pattern-recognition tools to help doctors isolate patient sub-types and deliver highly personalized, holistic treatment strategies.
Source: Semmelweis University
#WordMain #StudentNewsPortal #Europe #studentnews
About the Author
